PSYENCE BIOMEDICAL LTD Sales And Marketing Expense
PSYENCE BIOMEDICAL LTD (PBM) reported Sales And Marketing Expense of $48.67 thousand for the 3-month period ending 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2025-11-20
- PSYENCE BIOMEDICAL LTD sales and marketing expense for the quarter ending 2025-09-30 was $48.67K, a 82.22% decline year-over-year.
- PSYENCE BIOMEDICAL LTD sales and marketing expense for the quarter ending 2024-09-30 was $273.77K, a 24856.06% increase year-over-year.
- PSYENCE BIOMEDICAL LTD sales and marketing expense for the quarter ending 2023-09-30 was $1.10K.
| Period end | Sales And Marketing Expense 3 month | Sales And Marketing Expense 6 month | Sales And Marketing Expense 12 month |
|---|---|---|---|
| 2025-09-30 | $48.67K 6-K · filed 2025-11-20 | $154.98K 6-K · filed 2025-11-20 | |
| 2025-03-31 | $483.53K 20-F · filed 2025-06-25 | ||
| 2024-09-30 | $273.77K 6-K · filed 2025-11-20 | $320.71K 6-K · filed 2025-11-20 | |
| 2024-03-31 | $80.60K 20-F · filed 2025-06-25 | ||
| 2023-09-30 | $1.10K 6-K · filed 2025-01-23 | $2.12K 6-K · filed 2025-01-23 | |
| 2023-03-31 | $7.03K 20-F · filed 2025-06-25 |